Back
Corvus Pharmaceuticals Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
39
CRVS
Corvus Pharmaceuticals
Last Price:
$3.58
Seasonality Move:
14.14%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.68 | Sell |
| 20-day SMA: | 3.57 | Buy |
| 50-day SMA: | 3.65 | Sell |
| 200-day SMA: | 5.24 | Sell |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 3.52 | Buy |
| 50-day EMA: | 2.79 | Buy |
| 200-day EMA: | 1.14 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 472069 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.14 - 3.8) | Buy |
| Bollinger Bands (100): | (3.45 - 5.25) | Sell |
Corvus Pharmaceuticals Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 3.58 while CRVS 8-day simple moving average is 3.68, which is a Sell signal.
-
The stock price of CRVS is 3.58 while Corvus Pharmaceuticals 20-day SMA is 3.57, which makes it a Buy.
-
Corvus Pharmaceuticals 50-day simple moving average is 3.65 while CRVS share price is 3.58, making it a Sell technically.
-
CRVS stock price is 3.58 and Corvus Pharmaceuticals 200-day simple moving average is 5.24, creating a Sell signal.
CRVS Technical Analysis vs Fundamental Analysis
Sell
39
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a SellThe current Corvus Pharmaceuticals [CRVS] share price is $3.58. The Score for CRVS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
276.1M
Price in USD:
3.58
Share Volume:
660.9K
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.75
Sell
39
Corvus Pharmaceuticals (CRVS)
is a Sell
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?The Corvus Pharmaceuticals stock price is 3.58 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 3.58 while CRVS 8-day exponential moving average is 3.70, which is a Sell signal.
-
The stock price of CRVS is 3.58 while Corvus Pharmaceuticals 20-day EMA is 3.52, which makes it a Buy.
-
Corvus Pharmaceuticals 50-day exponential moving average is 2.79 while CRVS share price is 3.58, making it a Buy technically.
-
CRVS stock price is 3.58 and Corvus Pharmaceuticals 200-day simple moving average is 1.14, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is 0.27, suggesting Corvus Pharmaceuticals is a Buy
-
Corvus Pharmaceuticals Relative Strength Index (RSI) is 49.61, which suggest Corvus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Corvus Pharmaceuticals is (3.14 - 3.8), which suggest Corvus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Corvus Pharmaceuticals is (3.45 - 5.25), which suggest Corvus Pharmaceuticals is a Sell
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.